BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1198 related articles for article (PubMed ID: 19374581)

  • 41. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.
    Adra M; Lawrence KR
    Ann Pharmacother; 2004 Feb; 38(2):338-41. PubMed ID: 14742775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Neuner EA; Casabar E; Reichley R; McKinnon PS
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):228-33. PubMed ID: 20542203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
    Bhavnani SM; Prakhya A; Hammel JP; Ambrose PG
    Clin Infect Dis; 2009 Sep; 49(5):691-8. PubMed ID: 19635023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of severe infections caused by Staphylococcus aureus: a change in the vancomycin paradigm?
    Aranha Camargo LF
    Shock; 2008 Oct; 30 Suppl 1():67-9. PubMed ID: 18704006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics.
    Ruotsalainen E; Kardén-Lilja M; Kuusela P; Vuopio-Varkila J; Virolainen-Julkunen A; Sarna S; Valtonen V; Järvinen A
    J Infect; 2008 Apr; 56(4):249-56. PubMed ID: 18314197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes.
    Tong SY; Bishop EJ; Lilliebridge RA; Cheng AC; Spasova-Penkova Z; Holt DC; Giffard PM; McDonald MI; Currie BJ; Boutlis CS
    J Infect Dis; 2009 May; 199(10):1461-70. PubMed ID: 19392622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.
    Lodise TP; McKinnon PS; Levine DP; Rybak MJ
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3731-3. PubMed ID: 17664322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia.
    Jenkins TC; Price CS; Sabel AL; Mehler PS; Burman WJ
    Clin Infect Dis; 2008 Apr; 46(7):1000-8. PubMed ID: 18444816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multilevel epidural abscess formation with paraplegia in a healthy 33-year-old man caused by Staphylococcus aureus (MSSA).
    Abel R; von Baum H
    Infection; 2003 Oct; 31(5):359-61. PubMed ID: 14556064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Bacteremia due to methicillin-resistant Staphylococcus aureus (MRSA)].
    Funada H
    Nihon Rinsho; 1992 May; 50(5):1081-6. PubMed ID: 1507431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical identifiers of complicated Staphylococcus aureus bacteremia.
    Fowler VG; Olsen MK; Corey GR; Woods CW; Cabell CH; Reller LB; Cheng AC; Dudley T; Oddone EZ
    Arch Intern Med; 2003 Sep; 163(17):2066-72. PubMed ID: 14504120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Frequency of methicilin-resistant Staphylococcus aureus strains in clinical spacimens obtained from hospitalized patients in 2007].
    Mihajlović-Ukropina M; Medić D; Jelesić Z; Dautović R; Stefan-Mikić S; Sević S
    Med Pregl; 2008; 61 Suppl 1():27-30. PubMed ID: 19256065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).
    Gudiol F; Aguado JM; Almirante B; Bouza E; Cercenado E; Domínguez MÁ; Gasch O; Lora-Tamayo J; Miró JM; Palomar M; Pascual A; Pericas JM; Pujol M; Rodríguez-Baño J; Shaw E; Soriano A; Vallés J
    Enferm Infecc Microbiol Clin; 2015 Nov; 33(9):625.e1-625.e23. PubMed ID: 25937457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Impact of methicillin resistance on mortality and surveillance of vancomycin susceptibility in bacteremias caused by Staphylococcus aureus].
    Traverso F; Peluffo M; Louge M; Funaro F; Suasnabar R; Cepeda R
    Rev Argent Microbiol; 2010; 42(4):274-8. PubMed ID: 21229197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The first pediatric case of Staphylococcus aureus with heterogenous resistant to vancomycin endocarditis in Thailand.
    Phongsamart W; Srifeungfung S; Tiensasitorn C; Vanprapar N; Chearskul S; Chokephaibulkit K
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S264-8. PubMed ID: 16856450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Staphylococcus aureus septicemia in non-neutropenic adult patients hospitalized in internal medicine units.
    Gallucci F; Amato G; Esposito P; Belli CM; Russo R; Uomo G
    Rocz Akad Med Bialymst; 2005; 50():216-9. PubMed ID: 16358970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
    Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
    Grim SA; Rapp RP; Martin CA; Evans ME
    Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.
    del Río A; Gasch O; Moreno A; Peña C; Cuquet J; Soy D; Mestres CA; Suárez C; Pare JC; Tubau F; Garcia de la Mària C; Marco F; Carratalà J; Gatell JM; Gudiol F; Miró JM;
    Clin Infect Dis; 2014 Oct; 59(8):1105-12. PubMed ID: 25048851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.